Form 8-K - Current report:
SEC Accession No. 0001628280-20-003774
Filing Date
2020-03-18
Accepted
2020-03-18 17:16:50
Documents
3
Period of Report
2020-03-18
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K a2019q4-earningsrelease.htm 8-K 35686
2 EXHIBIT 99.1 a2019q4exhibit991earningsr.htm EX-99.1 393362
3 cumberlandpharmalogoa01.jpg GRAPHIC 37721
  Complete submission text file 0001628280-20-003774.txt   482192
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 20725514
SIC: 2834 Pharmaceutical Preparations